--A jury in Philadelphia ordered Johnson & Johnson to pay $8 billion in punitive damages to a man who claimed the company failed to warn users its antipsychotic drug Risperdal could cause breast growth, Reuters reported Tuesday.

--The pharmaceutical company was previously ordered to pay the man $680,000, the report said.

--Thousands of Risperdal cases are pending in Pennsylvania, the report said.

--J&J didn't immediately comment on the verdict, the report said

Full story: https://www.reuters.com/article/us-johnson-johnson-risperdal-verdict/jj-must-pay-8-billion-in-case-over-male-breast-growth-linked-to-risperdal-jury-idUSKBN1WN2HK?il=0

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

October 08, 2019 18:50 ET (22:50 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Johnson and Johnson Charts.